Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing. - Wikidata - wikimedia - TriplyDB

Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing.

Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing.

http://www.wikidata.org/entity/Q37358658

about

Feasibility, Acceptability And Adherence With Short Term Hiv Pre-Exposure Prophylaxis In Female Sexual Partners Of Migrant Miners In Mozambique.Comparison of Measures of Adherence to HIV Preexposure Prophylaxis among Adolescent and Young Men Who Have Sex with Men in the United States.Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy: the DOT-DBS Study.Adherence Measurements in HIV: New Advancements in Pharmacologic Methods and Real-Time Monitoring.Rapid measures of user's adherence to vaginal drug products using attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) and multivariate discriminant techniques.

P2860

Q38641084-2833EFA1-FBFB-429E-82AD-8A2AD0417295 Q45947819-4B7D08C1-1C35-47EE-929E-DDD6778C839C Q46323872-A7F449EE-8BE1-4335-8958-3CD7FF18E67F Q49587788-EE2EA0E7-E654-45B4-8A65-7B795EBB2AD2 Q55005002-E9DA75FB-C5DB-4A92-8E88-2ED107C2A334

P2860

Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing.

http://www.wikidata.org/entity/Q37358658

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing.

@en

Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing.

@nl

type

label

Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing.

@en

Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing.

@nl

prefLabel

Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing.

@en

Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing.

@nl

P1433

Q37358658-8E3243F6-3F33-421E-BB7B-9AD3E9ABC795

P1476

Q37358658-39FD5E0F-9AB8-44F7-BEB6-407B774C3927

P2093

Q37358658-0C7C1431-E2F0-47D8-A49C-BFBB3EA2808C

Q37358658-1CAFD5D6-745C-4F3D-B842-4C79E0F3575B

Q37358658-3CF56BDE-B94C-4885-943C-9E6DFEBD65E5

Q37358658-5A0DF985-F07A-40EC-AD0A-FE543626E6DA

Q37358658-611066C4-DE13-4252-BEF0-52BB5BEA868A

Q37358658-7C93EAF8-1D64-4A23-B573-40CB4882990E

Q37358658-97ED535B-E7B8-4427-8DBB-B7D23C870898

Q37358658-B97B2FC4-7955-448A-89B8-C966A9EE6CE7

Q37358658-D3BD67B8-A65A-46A0-8D86-2767ED4EE729

Q37358658-DC884BCB-1670-4D19-B191-158E8AFA6897

P2860

Q37358658-11258E61-D5AD-45DA-8E97-17361DE9D900

Q37358658-264F8245-5978-4634-BF88-3BD410EA5CCA

Q37358658-2DC01205-6CDB-48AC-84A8-26269026BECE

Q37358658-3436A816-6392-4E8F-9BDD-6DB275F5E31F

Q37358658-3CE9DCA9-117D-442B-BFB5-30A70725A29E

Q37358658-43CE8078-1284-49C0-8DC7-497A2C5341F4

Q37358658-56418F01-1D17-4983-AD0F-7C5E4089264F

Q37358658-5B3B786A-3580-4E70-BA40-3962931EFBB9

Q37358658-65F24126-49AC-4A32-907D-6BE9B68114C9

Q37358658-6C7C29A5-654B-485B-AE4E-80915688C78B

P304

Q37358658-FCF91F45-041D-47E0-803D-97CDEDA6D62B

P31

Q37358658-CC578459-BC1E-4EB2-BECA-1E34B1419CAA

P356

Q37358658-7469A60B-2280-4FDF-9A62-DEC0EE6D5468

P407

Q37358658-1332B4C4-9E11-4B0F-9545-EE4F19CEE591

P433

Q37358658-D51034B8-A2FC-472B-8A21-9E8677337D1E

P478

Q37358658-DAAD5AC8-4E2A-42DF-B761-66F628A33D3C

P50

Q37358658-07F676E6-0995-48AA-972E-597FD6088148

P577

Q37358658-0BF5F6EF-6C64-4D3A-A3CF-C6F8C4EF2537

P698

Q37358658-6E1A3FBF-7098-42E5-86F9-0BF0D2ACF65F

P932

Q37358658-0CF09A51-3DB7-44F1-9429-27DCEF71350A

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing.

@en

P2093

Albert Liu

http://www.w3.org/2001/XMLSchema#string

Craig M Wilson

http://www.w3.org/2001/XMLSchema#string

David V Glidden

http://www.w3.org/2001/XMLSchema#string

Edward M Gardner

http://www.w3.org/2001/XMLSchema#string

Jia-Hua Zheng

http://www.w3.org/2001/XMLSchema#string

Jose Castillo-Mancilla

http://www.w3.org/2001/XMLSchema#string

Kayla Campbell

http://www.w3.org/2001/XMLSchema#string

Kevin McAllister

http://www.w3.org/2001/XMLSchema#string

Lane R Bushman

http://www.w3.org/2001/XMLSchema#string

Peter L Anderson

http://www.w3.org/2001/XMLSchema#string

P2860

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

Preexposure prophylaxis for HIV infection among African women

Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana

Tenofovir-based preexposure prophylaxis for HIV infection among African women.

HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention.

Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection

Dose response for starting and stopping HIV preexposure prophylaxis for men who have sex with men.

Plasma Tenofovir, Emtricitabine, and Rilpivirine and Intracellular Tenofovir Diphosphate and Emtricitabine Triphosphate Pharmacokinetics following Drug Intake Cessation.

P304

6692-6697

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01017-16

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

Robert M. Grant

P577

2016-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27572401

http://www.w3.org/2001/XMLSchema#string

P932

5075074

http://www.w3.org/2001/XMLSchema#string